Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.

Publication ,  Journal Article
Daly, MB; Pilarski, R; Yurgelun, MB; Berry, MP; Buys, SS; Dickson, P; Domchek, SM; Elkhanany, A; Friedman, S; Garber, JE; Goggins, M; Khan, S ...
Published in: J Natl Compr Canc Netw
April 2020

The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic provide recommendations for genetic testing and counseling for hereditary cancer syndromes, and risk management recommendations for patients who are diagnosed with syndromes associated with an increased risk of these cancers. The NCCN panel meets at least annually to review comments, examine relevant new data, and reevaluate and update recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding criteria for high-penetrance genes associated with breast and ovarian cancer beyond BRCA1/2, pancreas screening and genes associated with pancreatic cancer, genetic testing for the purpose of systemic therapy decision-making, and testing for people with Ashkenazi Jewish ancestry.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

April 2020

Volume

18

Issue

4

Start / End Page

380 / 391

Location

United States

Related Subject Headings

  • Penetrance
  • Pancreatic Neoplasms
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Neoplastic Syndromes, Hereditary
  • Humans
  • Genetic Testing
  • Genetic Predisposition to Disease
  • Genetic Counseling
  • Genetic Association Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Daly, M. B., Pilarski, R., Yurgelun, M. B., Berry, M. P., Buys, S. S., Dickson, P., … Darlow, S. D. (2020). NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. J Natl Compr Canc Netw, 18(4), 380–391. https://doi.org/10.6004/jnccn.2020.0017
Daly, Mary B., Robert Pilarski, Matthew B. Yurgelun, Michael P. Berry, Saundra S. Buys, Patricia Dickson, Susan M. Domchek, et al. “NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.J Natl Compr Canc Netw 18, no. 4 (April 2020): 380–91. https://doi.org/10.6004/jnccn.2020.0017.
Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. J Natl Compr Canc Netw. 2020 Apr;18(4):380–91.
Daly, Mary B., et al. “NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.J Natl Compr Canc Netw, vol. 18, no. 4, Apr. 2020, pp. 380–91. Pubmed, doi:10.6004/jnccn.2020.0017.
Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pal T, Pederson HJ, Reiser G, Shannon KM, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Dwyer MA, Darlow SD. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. J Natl Compr Canc Netw. 2020 Apr;18(4):380–391.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

April 2020

Volume

18

Issue

4

Start / End Page

380 / 391

Location

United States

Related Subject Headings

  • Penetrance
  • Pancreatic Neoplasms
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Neoplastic Syndromes, Hereditary
  • Humans
  • Genetic Testing
  • Genetic Predisposition to Disease
  • Genetic Counseling
  • Genetic Association Studies